Low-cost high-throughput targeted sequencing for the accurate detection of respiratory tract pathogens
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.19685 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Changyan Ju und 8 weiteren Autor:innen. Beteiligte Einrichtung: Nanshan Center for Disease Control and Prevention, Shenzhen, China. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, COVID-19, SARS-CoV-2, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The current gold standard for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnosis by real-time reverse transcriptase polymerase chain reaction (RT-PCR) is limited by the number of genes that can be detected. In this study, we developed a low-cost and high-throughput next-generation sequencing technology that can overcome the limitations of real time RT-PCR. Methodology: A targeted sequencing panel (TSP) consisting of approximately 500 amplicons was designed. This panel could simultaneously detect a broad range of gene loci of SARS-CoV-2, and genes for the most common infectious viruses that affect the respiratory tract, in a single run and could include up to 96 samples. Four hundred and forty-eight samples and 31 control samples were analyzed independently with both TSP and RT-PCR, and the results were compared for accuracy and other indicators.
Results
TSP identified 50 SARS-CoV-2 positive samples with a 99.33% match to RT-PCR results. It is not surprising that TSP also identified multiple infections from the 96 samples, whereas RT-PCR could not. Thus, TSP was able to accurately diagnose the samples which could not be identified based on single RT-PCR test.
Conclusions
Our data demonstrated that TSP is a fast and accurate testing method for identifying multiple pathogen infections of the respiratory tract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nanshan Center for Disease Control and Prevention, Shenzhen, China.
- Nanan Center for Disease Control and Prevention, Chongqing, China.
- The First Affiliated Hospital of Sun Yue-sen University, Guangzhou, China.
- Guangdong Ardent BioMed Co., Ltd, Guangzhou, China.
Zitieren
APA
Ju, C., Zhou, C., Deng, Z., Gao, J., Jiang, W., Zeng, H., Huang, H., Duan, Y., & Deng, D. X. (2024). Low-cost high-throughput targeted sequencing for the accurate detection of respiratory tract pathogens. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19685
Vancouver
Ju C, Zhou C, Deng Z, Gao J, Jiang W, Zeng H, et al. Low-cost high-throughput targeted sequencing for the accurate detection of respiratory tract pathogens. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19685
BibTeX
@article{Ju2024,
author = {Ju, Changyan and Zhou, Chengbosen and Deng, Zhezhi and Gao, Jingwei and Jiang, Weizhao and Zeng, Hanbing and Huang, Haiwei and Duan, Yongxiang and Deng, David X},
title = {Low-cost high-throughput targeted sequencing for the accurate detection of respiratory tract pathogens},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.19685}
}
EUVIMED